title: Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort.
abstract: Specialized health services, such as blood and marrow transplantation (BMT), are usually based in large urban centers. Previous research has suggested that rural patients undergoing BMT have a higher risk of death. We performed a cohort study using data from both the Manitoba BMT Program and the provincial Cancer Registry to determine whether patients from the rural areas would have inferior survival after BMT and whether rural patients have reduced access to BMT. A total of 463 adult Manitobans, who underwent BMT between January 1990 and December 2006, were assessed. We analyzed area of residence (rural vs urban), disease and BMT characteristics, and calculated the OS. Patients undergoing autologous and allogeneic transplants were analyzed separately. When adjusted for gender, age at BMT and year of BMT, area of residence was not a significant predictor of mortality. A relative survival analysis was also conducted, and area of residence was again not a significant predictor of mortality. To measure access to BMT in urban vs rural patients, we evaluated all patients with newly diagnosed Hodgkin's Lymphoma (HL) during this same period. Of 432 Manitobans diagnosed with HL, 182 (42%) were rural and 250 (58%) were urban. In contrast, 69% of patients undergoing transplant for HL were urban. In conclusion, using population-based data from a Canadian province, we were unable to show a survival disadvantage for rural patients after controlling for other variables. BMT utilization in rural populations deserves further study.
authors.affiliation: Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. umpaul02@cc.umanitoba.ca
authors.forename: K
authors.initials: K
authors.lastname: Paulson
authors.forename: P
authors.initials: P
authors.lastname: Lambert
authors.forename: C
authors.initials: C
authors.lastname: Bredeson
authors.forename: A
authors.initials: A
authors.lastname: Demers
authors.forename: J
authors.initials: J
authors.lastname: Nowatzki
authors.forename: E
authors.initials: E
authors.lastname: Richardson
authors.forename: M
authors.initials: M
authors.lastname: Rubinger
authors.forename: D
authors.initials: D
authors.lastname: Szwajcer
authors.forename: M D
authors.initials: MD
authors.lastname: Seftel
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000706:statistics & numerical data; D002170:Canada / Q000453:epidemiology; D015331:Cohort Studies; D003625:Data Collection; D005260:Female; D006297:Health Services Accessibility / Q000706:statistics & numerical data; D018380:Hematopoietic Stem Cell Transplantation / Q000706:statistics & numerical data; D006689:Hodgkin Disease / Q000453:epidemiology / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012424:Rural Population; D033581:Stem Cell Transplantation / Q000706:statistics & numerical data*; D016019:Survival Analysis; D016896:Treatment Outcome; D014505:Urban Population